A Phase 2A study of PTC518 in patients with Huntington's Disease
A PHASE 2A, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY OF PTC518 IN SUBJECTS WITH HUNTINGTON'S DISEASE - PIVOT-HD A PHASE 2A, RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING STUDY TO EVALUATE THE SAFETY AND EFFICACY O ...
Product Name: PTC518 tablet 5 mg Product Code: PTC518 INN or Proposed INN: Not available Other descriptive name: PTC518 Product Name: PTC518 tablet 20 mg Product Code: PTC518 INN or Proposed INN: Not available Other descriptive name: PTC518Product Name: PTC518tablet 5 mg Product Code: PTC518 INN or Proposed INN: Not available Other descripti ...
A Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)
A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of PTC518 in Subjects With Huntington's Disease A Phase 2A, Randomized, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy o ...
Huntington Disease
Drug: PTC518;Drug: Placebo
PTC Therapeutics
NULL
Recruiting
25 Years
N/A
All
162
Phase 2
United States;Australia;France;Germany;Netherlands;United Kingdom